American International Group’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-59,749
| Closed | -$227K | – | 3234 |
|
|
2020
Q1 | $227K | Sell |
59,749
-2,975
| -5% | -$12.8K | ﹤0.01% | 1843 |
|
|
2019
Q4 | $319K | Sell |
62,724
-1,678
| -3% | -$8.88K | ﹤0.01% | 1945 |
|
|
2019
Q3 | $326K | Buy |
64,402
+673
| +1% | +$3.36K | ﹤0.01% | 1890 |
|
|
2019
Q2 | $393K | Sell |
63,729
-30
| -0% | -$145 | ﹤0.01% | 1836 |
|
|
2019
Q1 | $296K | Sell |
63,759
-1,734
| -3% | -$7.85K | ﹤0.01% | 1994 |
|
|
2018
Q4 | $275K | Sell |
65,493
-691
| -1% | -$3.52K | ﹤0.01% | 1996 |
|
|
2018
Q3 | $415K | Buy |
66,184
+9,094
| +16% | +$69.9K | ﹤0.01% | 2005 |
|
|
2018
Q2 | $459K | Buy |
57,090
+11,871
| +26% | +$90.6K | ﹤0.01% | 1892 |
|
|
2018
Q1 | $337K | Sell |
45,219
-10,964
| -20% | -$72.9K | ﹤0.01% | 1952 |
|
|
2017
Q4 | $334K | Buy |
56,183
+225
| +0.4% | +$1.37K | ﹤0.01% | 2020 |
|
|
2017
Q3 | $412K | Buy |
55,958
+3,054
| +6% | +$19.4K | ﹤0.01% | 1872 |
|
|
2017
Q2 | $359K | Buy |
52,904
+10,040
| +23% | +$74.1K | ﹤0.01% | 1920 |
|
|
2017
Q1 | $405K | Buy |
42,864
+2,835
| +7% | +$28.3K | ﹤0.01% | 1736 |
|
|
2016
Q4 | $346K | Sell |
40,029
-104
| -0.3% | -$769 | ﹤0.01% | 1866 |
|
|
2016
Q3 | $254K | Buy |
40,133
+61
| +0.2% | +$369 | ﹤0.01% | 2014 |
|
|
2016
Q2 | $169K | Sell |
40,072
-718
| -2% | -$3.47K | ﹤0.01% | 2251 |
|
|
2016
Q1 | $178K | Sell |
40,790
-64,796
| -61% | -$289K | ﹤0.01% | 2884 |
|
|
2015
Q4 | $647K | Buy |
105,586
+8,448
| +9% | +$55.4K | ﹤0.01% | 1822 |
|
|
2015
Q3 | $556K | Sell |
97,138
-29,594
| -23% | -$227K | ﹤0.01% | 1928 |
|
|
2015
Q2 | $945K | Sell |
126,732
-4,040
| -3% | -$24.4K | ﹤0.01% | 1636 |
|
|
2015
Q1 | $782K | Sell |
130,772
-43,192
| -25% | -$272K | ﹤0.01% | 1798 |
|
|
2014
Q4 | $1.32M | Sell |
173,964
-2,660
| -2% | -$15.9K | 0.01% | 1361 |
|
|
2014
Q3 | $917K | Buy |
176,624
+2,465
| +1% | +$12.3K | ﹤0.01% | 1625 |
|
|
2014
Q2 | $751K | Buy |
174,159
+17,903
| +11% | +$68.4K | ﹤0.01% | 1820 |
|
|
2014
Q1 | $639K | Buy |
156,256
+116,743
| +295% | +$597K | ﹤0.01% | 1881 |
|
|
2013
Q4 | $211K | Buy |
39,513
+5,301
| +15% | +$23.3K | ﹤0.01% | 2738 |
|
|
2013
Q3 | $172K | Buy |
34,212
+2,764
| +9% | +$15K | ﹤0.01% | 2864 |
|
|
2013
Q2 | $140K | Buy |
+31,448
| New | +$141K | ﹤0.01% | 2860 |
|
Other funds holding PGNX
American International Group's PGNX Position: Q2 2020 in Review
American International Group sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 59,749 shares — an estimated $227K sold.
American International Group first reported a position in PGNX in Q2 2013 and held it in 28 quarters. The position peaked at $1.32M in Q4 2014. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.
- American International Group reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
- American International Group sold 59,749 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $227K.
- American International Group first reported a position in Progenics Pharmaceuticals Inc in Q2 2013 and held it in 28 quarters.
- American International Group's Progenics Pharmaceuticals Inc position peaked at $1.32M in Q4 2014.
- 3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.
Based on American International Group's 13F filing for Q2 2020, filed 12 Aug 2020.